Literature DB >> 8267396

Vitamin B12 malabsorption after irradiation for gynaecological tumours.

A Snijders-Keilholz1, G Griffioen, J Davelaar, J B Trimbos, J W Leer.   

Abstract

The serum vitamin B12 levels were determined in 44 asymptomatic patients at least one year after completion of pelvic irradiation for a gynaecological tumour. Ten patients (23%) were found to have decreased levels of serum vitamin B12, of which six (14%) were assumed to be caused by malabsorption due to radiation damage to the terminal ileum as no other reason for a lower vitamin B12 level could be detected. Neither the radiation dose or volume nor the manifestation of acute or late radiation side effects appeared to be correlated with the finding of decreased levels of vitamin B12. It is concluded that even in asymptomatic patients who received pelvic irradiation, serum vitamin B12 levels can serve as a marker for radiation enteropathy. It is advocated to check vitamin B12 levels prior to the radiation treatment as well as during the follow-up of these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267396

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Intensity-modulated radiation therapy in gynecologic malignancies.

Authors:  Joseph K Salama; John C Roeske; Neil Mehta; Arno J Mundt
Journal:  Curr Treat Options Oncol       Date:  2004-04

2.  Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicity.

Authors:  Robson Ferrigno; Adriana Santos; Lidiane C Martins; Eduardo Weltman; Michael J Chen; Roberto Sakuraba; Cleverson P Lopes; José C Cruz
Journal:  Radiat Oncol       Date:  2010-12-14       Impact factor: 3.481

3.  A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences.

Authors:  Ann Muls; Alexandra Taylor; Susan Lalondrelle; Mohammed Kabir; Christine Norton; Ailsa Hart; H Jervoise Andreyev
Journal:  Support Care Cancer       Date:  2020-01-29       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.